Company alerts ❯
-
Histogenannounces US patent covering CTS-2090 for inflammatory diseases. Read more
Histogen (NAS: HSTO)
Also known as: #N/ALT 2203203 of 520Histogen is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.Longevity pillar- Renewal
- Treatment
Longevity domain:- Regeneration
- Advanced Aesthetics
Location: United StatesYear founded: 01-Jan-07Longevity target: Aging DiseaseProprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023 -
TheOuraring just got new sleep features that even the Apple Watch doesn’t have. Read more
Oura Health
Also known as: ŌuraLT 2339339 of 520Oura Health is the developer of a wellness wearable ring designed to track and improve the quality of sleep and performance. The company's product tracks sleep quality, stages, ECG level resting heart rate and variability as well as body temperature during the night through an intelligent data-driven plan by detecting changes in blood pulse volume, enabling users to improve their sleep, overall health, and align to their natural circadian rhythm.Longevity pillar- Prevention
Longevity domain:- Longevity lifestyle
Location: FinlandYear founded: 01-Jan-13Longevity target: Longevity determinantProprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023 -
TruDiagnosticand NADMED launch new blood diagnostic in US. Read more
TruDiagnostic
Also known as: #N/ALT 2441441 of 520Founded in 2020, TruDiagnostic has already been making headway in the longevity industry with a mission to improve people's lives. TruDiagnostic wants to arm patients and physicians with information, enabling them to make the right decisions at the right times through insights found in the fluid epigenomeLongevity pillar- Diagnostic
- Prevention
Longevity domain:- Longevity diagnostics
Location: United StatesYear founded: 01-Jan-20Longevity target: Aging DriverProprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023 -
BlueRock Therapeuticsto use Rune Labs' clinical trial platform to better characterize Parkinson's disease state in cell therapy trials. Read more
BlueRock Therapeutics
Also known as: BlueRockLT 207575 of 520BlueRock is a developer of a new generation of authentic and engineered cell therapies created to impact various diseases. The company develops induced pluripotent stem cell therapies to cure a range of diseases with the help of regenerative medicines across neurology, cardiology and immunology indications, thus enabling healthcare professionals to deliver advanced care and ensure fast recovery of the patients suffering from intractable diseases. BlueRock has a superior understanding and know-how of the intricate requirements needed to differentiate pluripotent cells into specific cells in the body – neuronal cells, cardiac cells, immune cells and more.Longevity pillar- Renewal
- Treatment
Longevity domain:- Regeneration
- Longevity Genetics
Location: United StatesYear founded: 01-Jan-16Longevity target: Aging Disease, Aging DriverProprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023 -
Celmatixand global collaborators release findings from largest genetic study to date on endometriosis. Read more
Celmatix
Also known as: #N/ALT 209797 of 520Celmatix is a preclinical-stage biotech transforming women’s lives through better ovarian health.Longevity pillar- Treatment
Longevity domain:- Discovery platforms
- Reproductive longevity
Location: United StatesYear founded: 01-Jan-09Longevity target: Aging Driver, Aging DiseaseProprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023 -
CambrianBio reveals new pipeline company with focus on AMPK activation. Read more
Cambrian Biopharma
Also known as: #N/ALT 208484 of 520Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. Over the next 10 or 15 years, Cambrian wants to bring the way that we treat the diseases of aging into the 21st century by preventing them from happening, instead of waiting for people to get sickLongevity pillar- Prevention
Longevity domain:- Longevity platforms
- Longevity drugs
Location: United StatesYear founded: 01-Jan-19Longevity target: Aging DriverProprietary analysis by Longevity.Technology, according to Pitchbook Data data as of March 21, 2023